(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology >  Ethical Pharmaceuticals
 
 Ethical Pharmaceuticals Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  Next »
United States Market for Ankylosing Spondylitis Pharmacotherapy

This research service covers the United States market for ankylosing spondylitis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies; background standard of care therapies are not covered in this study....

 

$6000.00
       
Research Report on China's Veterinary Active Pharmaceutical Ingredient and Chemical Preparation Industry

On the basis of an exposition about the status quo of China's veterinary active pharmaceutical ingredients and chemical preparations industry in 2011, the report will make an in-depth analysis of the development environment, enterprises structure and scale, as well as the circulation and marketing of China's veterinary chemicals industry. Besides, the report will also make a detailed and objective analysis of the development trend of China's veterinary chemicals industry, aiming to be of help to the scientific judgment of the investment value of China's veterinary chemicals industry.

 

$6000.00
       
Competitive Analysis of the Global Opioid Therapeutics Market

This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development....

 

$6000.00
       
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

Summary

Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant unmet needs still exist....

 

$5995.00
       
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

Summary

Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it occurs primarily in older adults’ =50 years old, with an abysmal prognosis (3-5 years following diagnosis)....

 

$5995.00
       
Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers

“Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers” Report integrates deep research of top players in the pharmaceutical industry with our proprietary analysis and ranking methodology to reveal top performers, industry trends, and the strategies that successful companies are using to stay ahead in the increasingly demanding pharmaceutical marketplace. Clients can use this report for strategic planning and tracking of competitor strategies....

 

$5700.00
       
Lung Cancer Drug Pipeline Update 2013

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D and chemotherapy use, the median overall survival of NSCLC patient’s remains below 12 months....

 

$5621.25
       
PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022

“PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs....

 

$4995.00
       
PharmaPoint: Alzheimer’s Disease - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer’s Disease - Germany Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs....

 

$4995.00
       
PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs....

 

$4995.00
       
Drug Self-Administration Markets to 2016

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies....

 

$4850.00
       
Therapeutic Proteins to 2014

In recent years, the number of protein]based pharmaceuticals reaching the marketplace has increased exponentially. The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution....

 

$4850.00
       
Chinese Markets for Cardiovascular Drugs

China's demand for cardiovascular drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow....

 

$4000.00
       
Chinese Markets for Allergy Drugs

China's demand for allergy drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow....

 

$4000.00
       
Chinese Markets for Kidney Cancer Treatment Drugs

China's demand for kidney cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow....

 

$4000.00
       
Report on China's Veterinary Biologics Industry Investment

The report will make a detailed and objective analysis of the development trend of China's veterinary biologics industry, aiming to be of help to the scientific judgment of the investment value of China's veterinary biologics industry.

 

$4000.00
       
The World Market for Over The Counter (OTC) Drugs

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs....

 

$3995.00
       
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....

 

$3995.00
       
« Previous     1  2  3  4  5  6  7  8   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X